It is estimated that approximately 1 million patients in the United States are currently taking Avandia (generic name: rosiglitazone). This popular drug is intended to treat Type 2 diabetes by improving blood sugar control. Since its approval by the Food and Drug Administration (FDA) in 1999, Avandia has been linked to serious cardiovascular side effects.
Because a diabetic patient will already be at an increased risk of cardiac problems, taking Avandia may only increase that risk and may therefore have deadly results.
These risks spurred the FDA to demand GlaxoSmithKline to include a black-box warning on Avandia.
In addition to cardiovascular events such as heart attack or stroke, Avandia may be linked to such side effects as liver toxicity, low blood pressure, edema, weight gain, elevated lipids and anemia. If you or a loved one was prescribed Avandia and has experienced any dangerous side effect as a result, it is important to consider your legal rights.
